Predicting BCG Response | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Predicting BCG Response	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not stated	2026-07-06		NCT04564781

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cedars-Sinai Medical Center	161
Kyoto University	9
National Cancer Institute (NCI)	3015
Nonagen Bioscience Corporation	5
University of California, Los Angeles	355
University of California, San Francisco	637

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cedars-Sinai Medical Center	Los Angeles	United States	392
Kyoto University	Kyoto	Japan	2
UCLA	Los Angeles	United States	80
UCSF	San Francisco	United States	27
University of Queensland	Brisbane	Australia	1
University of Texas Southwestern	Dallas	United States	73